share_log

UBS Upgrades Viatris to Neutral, Raises Price Target to $12

Benzinga Real-time News ·  Nov 10, 2022 04:56

UBS analyst Ashwani Verma upgrades Viatris (NASDAQ:VTRS) from Sell to Neutral and raises the price target from $9 to $12.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment